These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1155916)

  • 1. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
    Bonner DP; Tewari RP; Solotorovsky M; Mechlinski W; Schaffner CP
    Antimicrob Agents Chemother; 1975 Jun; 7(6):724-9. PubMed ID: 1155916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal activity of pyrrolnitrin.
    Gordee RS; Matthews TR
    Appl Microbiol; 1969 May; 17(5):690-4. PubMed ID: 5785951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.
    Graybill JR; Williams DM; Van Cutsem E; Drutz DJ
    Rev Infect Dis; 1980; 2(4):551-58. PubMed ID: 6255531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
    Kobayashi GS; Little JR; Medoff G
    Antimicrob Agents Chemother; 1985 Mar; 27(3):302-5. PubMed ID: 3994345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of progressive disseminated histoplasmosis with amphotericin B methyl ester.
    Neihart RE; Hinthorn DR; Hoeprich PD; Liu C
    Diagn Microbiol Infect Dis; 1989; 12(1):17-9. PubMed ID: 2714068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of mycoses of the inner organs].
    Scholer HJ
    Schweiz Med Wochenschr; 1968 Apr; 98(16):602-11. PubMed ID: 5688589
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome).
    Adler-Moore JP; Chiang SM; Satorius A; Guerra D; McAndrews B; McManus EJ; Proffitt RT
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():63-71. PubMed ID: 1778893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B lipid complex therapy of experimental fungal infections in mice.
    Clark JM; Whitney RR; Olsen SJ; George RJ; Swerdel MR; Kunselman L; Bonner DP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):615-21. PubMed ID: 2069367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis.
    Kitahara M; Kobayashi GS; Medoff G
    J Infect Dis; 1976 Jun; 133(6):663-8. PubMed ID: 932494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neohepataene on experimental systemic mycoses in mice.
    Lones GW; Pggott WR; Hill WB
    Sabouraudia; 1968 Oct; 6(4):334-8. PubMed ID: 5726644
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative sensitivity of Naegleria fowleri to amphotericin B and amphotericin B methyl ester.
    Ferrante A
    Trans R Soc Trop Med Hyg; 1982; 76(4):476-8. PubMed ID: 6926763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fungal diseases. A statement by the committee on therapy.
    Am Rev Respir Dis; 1969 Dec; 100(6):908-10. PubMed ID: 5357705
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
    Parmegiani RM; Loebenberg D; Antonacci B; Yarosh-Tomaine T; Scupp R; Wright JJ; Chiu PJ; Miller GH
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1756-60. PubMed ID: 3324961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of the systemic mycoses.
    Newberry WM
    Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of systemic mycoses.
    Abernathy RS
    Medicine (Baltimore); 1973 Sep; 52(5):385-94. PubMed ID: 4725961
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A9145, a new adenine-containing antifungal antibiotic. II. Biological activity.
    Gordee RS; Butler TF
    J Antibiot (Tokyo); 1973 Aug; 26(8):466-70. PubMed ID: 4600794
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
    Perfect JR; Durack DT
    Antimicrob Agents Chemother; 1985 Dec; 28(6):751-5. PubMed ID: 4083860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.